Found 42 matching trials
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) N/A The study investigators are interested in learning more about how drugs, th...
Show More Location
Phoenix Children's Hospital
Learn More & Join Trial
Effects of Physical Therapy and Dalfampridine on Functional Mobility in Non Ambulatory Persons With Multiple Sclerosis PHASE2 The goal of this interventional double blind, randomized placebo controlled...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study Of Oral PF-02341066, A C-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer PHASE1 PF-02341066 may work in cancer by blocking the cell growth, migration and i...
Show More Location
University of California, Irvine Medical Center
Learn More & Join Trial
Does Fampridine SR Improve Cognitive Fatigue in Multiple Sclerosis Patients? PHASE2 Multiple Sclerosis (MS) patients often complain of cognitive fatigue. There...
Show More Location
London Health Sciences Center and St. Joseph's Heathcare Center (Parkwood)
Learn More & Join Trial
Amifampridine Phosphate for the Treatment of Congenital Myasthenic Syndromes PHASE3 This randomized, double-blind, controlled, outpatient two-period, two-treat...
Show More Location
UCLA Department of Neurology
Learn More & Join Trial
A New Medicine to Treat Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) PHASE4 Determine whether dalfampridine (Ampyra) can improve visual function in pat...
Show More Location
Neuro-Ophthalmologic Associates, PC
Learn More & Join Trial
4-Aminopyridine, Atenolol, or Placebo in Patients With Vestibular Migraine PHASE2 This phase 2 randomized study will be used to test the efficacy of 4-aminop...
Show More Location
Massachusetts Eye and Ear Infirmary
Learn More & Join Trial
4-Aminopyridine to Treat Skin Burns PHASE2 Many patients suffer from traumatic burns and current treatments do not inc...
Show More Location
University of Arizona
Learn More & Join Trial
A Safety and Efficacy Study of Oral Prolonged-Release Fampridine (BIIB041) in Japanese Participants With Multiple Sclerosis PHASE3 This is a multicenter study conducted in 3 parts. Part A is a double-blind ...
Show More Learn More & Join Trial
Open Label Extension Study to Evaluate the Safety and Tolerability of Oral Fampridine-Sustained Release (SR) in Canadian Participants With Multiple Sclerosis Who Participated in Acorda Extension Trials. PHASE3 The primary objective of the study is to evaluate the long-term safety and ...
Show More Location
Foothills Medical Center
Learn More & Join Trial